66--Illumina MiSeq i100 Series system
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The U.S. Department of the Interior (DOI), on behalf of the National Cancer Institute (NCI), has issued a Special Notice announcing its intent to award a sole source, firm-fixed-price contract to Illumina, Inc. for one Illumina MiSeq i100 Plus Sequencing System. This system, including delivery, installation, and training, is required to support centralized sequencing operations at NCI. Capability statements from interested parties are due by April 13, 2026, at 10:00 A.M. ET.
Scope of Work
This acquisition is for one (1) Illumina MiSeq i100 Plus Sequencing System. The system is critical for replacing aging iSeq and legacy MiSeq instruments, aiming to improve run reliability, streamline workflows, and provide flexible support for small- and mid-scale sequencing projects. The OEM, Illumina, is identified as the sole entity capable of providing this system, ensuring compatibility with existing Government-owned Illumina platforms, associated consumables, integrated DRAGEN secondary analysis functionality, and necessary installation and training services. Procuring from Illumina avoids interruptions to ongoing research.
Contract & Timeline
- Contract Type: Firm-Fixed-Price (FFP)
- Delivery: No later than 12 weeks after contract award.
- Set-Aside: Intended as a Sole Source acquisition.
- Capability Statement Due: Monday, April 13, 2026, by 10:00 A.M. ET.
- Published Date: April 3, 2026.
Submission Requirements
This is a Notice of Intent to Sole Source, not a request for competitive quotes. However, interested parties may express their interest and demonstrate their capability to meet the requirement by submitting a capability statement.
- Submission Method: Electronically via email.
- Email Contacts: Bridgette Ornelas (bridgette_ornelas@ibc.doi.gov) and Desmond Harris (desmond_harris@ibc.doi.gov).
- Format: Microsoft Office compatible or Adobe Acrobat.
- Page Limit: Not to exceed ten (10) pages.
- File Size Limit: Maximum 8 MB.
Evaluation & Notes
The Government will consider all capability statements received by the deadline to determine if a competitive acquisition is feasible. A determination not to compete this action based on responses is solely within the Government's discretion. The Government reserves the right to issue an RFQ. Information received is for market research purposes only. The Government will not reimburse for any information or administrative costs incurred. Marketing brochures and generic company literature will not be considered. Failure to address all requested information may result in a determination that the responder is not capable.